Embedded Files
Reliable and affordable in vitro diagnosis test for early detection of women's disease.
Reliable and affordable in vitro diagnosis test for early detection of women's disease.
Fundraising Status
Fundraising Status
Series A
Fundraising Target: 4M
Schedule:
For Series B in Q3, 2023
Revenue (USD)
Revenue (USD)
2022: 34K
2023 Target: 350K
Competitors
Competitors
DotLab
Endodiag
US Objective
US Objective
Expected Results
Expected Results
Fundraising
Seeking for Business Partners
Seeking for Strategic Investors
Specific Organizations/VCs to Engage
Specific Organizations/VCs to Engage
Quest
Mayo clinic
ACA plan
Private insurance company with women's health coverage
Company Details
Company Details
Company description
Company description
V-CHECK INC is a Taiwan-based Med-tech company that specializes in developing innovative diagnostic technology for women's health. Since its inception in 2017, the company has been dedicated to provide reliable and cost-effective in vitro detection products for women's diseases, particularly for those without sensitive biomarkers for early diagnosis.
Core Technology
Core Technology
V-CHECK's team has extensive experience in high-throughput biomarker screening technology and is capable of designing testing platforms that cater to patients' needs and clinical settings.
V-CHECK's team is highly skilled in the manufacturing of various immunoassay testing platforms and reagents under the ISO13485 quality system standard for IVD products. This ensures that V-CHECK made products are reliable with good quality.
One pager poster_V CHECK.pdfTeam Members
Team Members
You can meet her in person:
04/27-28 Maryland Spinoff
5/1-4 SelectUSA Summit (Maryland)
Sophia Lin, Director, Clinical & Regulatory Affairs
Sophia Lin, Director, Clinical & Regulatory Affairs
You can meet her in person:
04/27-28 Maryland Spinoff
5/1-4 SelectUSA Summit (Maryland)
Media Exposures
Media Exposures
Page updated
Report abuse